Allergan Issues Worldwide Recall of Textured Breast Implants

Allergan is recalling some of its textured breast implants and tissue expanders due to the risk of cancer. The FDA requested today that Allergan recall specific models of its textured breast implants due to the risk of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, a rare type of cancer of the immune system. Following the FDA’s announcement, Allergan issued a worldwide recall of its Biocell textured breast implants and tissue expanders. “Allergan is taking this action as a precaution following notification of recently updated global safety information concerning the uncommon incidence of breast implant-associated anaplastic large cell lymphoma provided by the U.S. Food and Drug Administration,” Allergan said in statement. A representative for the company did not immediately respond to request for comment. According to the FDA, there have been 573 unique cases worldwide of BIA-ALCL and 33 patient deaths. The federal agency said of the 573 unique cases of BIA-ALCL, 481 are attributed to Allergan implants. “Of the 33 patient deaths the FDA is reporting today, 12 of the 13 patients for which the manufacturer of the implant is known, are confirmed to have an Allergan breast implant at the time of their BIA-ALCL diagnosis,” the FDA said. The recall of Allergan’s Biocell textured breast

Follow WWD on Twitter or become a fan on Facebook.

Read More...

from WWDWWD https://ift.tt/2K357wh
via